In a patient with low total iron‑binding capacity (TIBC), low 24‑hour urine copper, and borderline‑high ferritin, what is the most likely diagnosis and what are the recommended diagnostic and therapeutic steps?

Low TIBC, Low 24-Hour Urine Copper, and Borderline-High Ferritin: Diagnostic Approach

This constellation of findings—low TIBC with borderline-high ferritin—most strongly suggests anemia of chronic disease (ACD) or chronic inflammation, not iron deficiency, and you should immediately evaluate for underlying inflammatory, infectious, malignant, or chronic disease processes.

Understanding the Laboratory Pattern

The key to interpreting these results lies in recognizing that low TIBC (which reflects low transferrin) combined with elevated or borderline-high ferritin is the hallmark pattern of inflammation-driven anemia, not iron deficiency 1. This is critical because:

• In true iron deficiency without inflammation: You would expect LOW ferritin (<30 ng/mL), LOW transferrin saturation (<16%), and HIGH TIBC (>350 μg/dL) as the body attempts to maximize iron transport capacity 2

• In anemia of chronic disease (ACD): Ferritin is typically >100 ng/mL with transferrin saturation <16% and LOW or normal TIBC 1. The inflammation causes iron sequestration in reticuloendothelial cells, making ferritin an acute-phase reactant that rises despite functional iron deficiency 3

Your patient's pattern matches ACD, where low TIBC indicates decreased transferrin synthesis due to chronic inflammation 4, 5. The borderline-high ferritin further supports this, as ferritin elevates with inflammation even when functional iron deficiency exists 1.

Clinical Significance of Low TIBC

Low TIBC is particularly concerning because it predicts:

• Malnutrition and poor nutritional status in chronic disease patients 4, 5
• Increased all-cause mortality in hemodialysis and chronic kidney disease patients 6, 7
• Progressive muscle loss in maintenance dialysis patients 5

The low TIBC suggests either chronic inflammation suppressing transferrin production or protein-energy malnutrition—both require urgent evaluation 4.

The Low 24-Hour Urine Copper Finding

The low urine copper is likely a red herring in this context. While Wilson's disease causes low serum ceruloplasmin and high urine copper (>100 μg/24h), your patient has LOW urine copper, which essentially rules out Wilson's disease. Low urine copper can occur with:

• Malnutrition/low dietary copper intake
• Severe protein loss (since ceruloplasmin carries copper)
• Chronic inflammatory states affecting copper metabolism

This finding reinforces the suspicion of chronic disease or malnutrition rather than suggesting a primary copper metabolism disorder.

Immediate Diagnostic Steps

You must determine the inflammatory status before proceeding further 1:

1. Measure inflammatory markers immediately:

   • C-reactive protein (CRP)
   • Erythrocyte sedimentation rate (ESR)
   • Complete blood count with differential
   • These are essential because ferritin interpretation depends entirely on whether inflammation is present 1

2. Calculate transferrin saturation (if serum iron available):

   • TSAT = (serum iron ÷ TIBC) × 100
   • TSAT <16% with ferritin >100 ng/mL confirms ACD 1
   • TSAT <16% with ferritin 30-100 ng/mL suggests mixed iron deficiency and ACD 1

3. Assess for underlying chronic conditions:

   • Chronic kidney disease (check creatinine, eGFR) 3
   • Malignancy screening (age-appropriate)
   • Inflammatory bowel disease
   • Rheumatologic conditions
   • Chronic infections
   • Heart failure 8

4. Nutritional assessment:

   • Serum albumin
   • Total protein
   • Prealbumin if available
   • Low TIBC correlates strongly with malnutrition 4, 5

Most Likely Diagnoses (in order of probability)

1. Anemia of Chronic Disease/Inflammation with possible functional iron deficiency
2. Protein-energy malnutrition with secondary effects on iron metabolism
3. Chronic kidney disease (given the mortality associations with low TIBC in CKD) 6, 7
4. Occult malignancy (ferritin as tumor marker, low TIBC from inflammation)
5. Mixed picture: Combination of true iron deficiency masked by inflammation

Therapeutic Approach

Do NOT start iron supplementation until you clarify the inflammatory status 1:

If Inflammation is Present (elevated CRP/ESR):

• Treat the underlying inflammatory condition first 1
• If ferritin is 30-100 ng/mL with TSAT <16%: Consider iron supplementation after addressing inflammation 1
• If ferritin >100 ng/mL: This is likely inflammatory iron sequestration; giving more iron may be harmful 3
• Trial of IV iron (50-125 mg weekly for 8-10 doses) can differentiate functional iron deficiency from inflammatory iron block: if no erythropoietic response occurs, stop iron and focus on treating inflammation 3

If No Inflammation (normal CRP/ESR):

• Ferritin <30 ng/mL would indicate true iron deficiency requiring oral iron supplementation 1
• But your patient has borderline-HIGH ferritin, making pure iron deficiency unlikely
• Focus on identifying cause of low TIBC (malnutrition, protein loss, chronic disease)

Critical Pitfalls to Avoid

1. Do not interpret ferritin in isolation—it is an acute-phase reactant and can be falsely elevated by inflammation, making iron-replete patients appear iron-sufficient 1, 3

2. Do not assume low TIBC means iron overload—low TIBC actually indicates low transferrin from inflammation or malnutrition, not excess iron 4, 5

3. Do not give empiric iron without checking inflammatory markers—this can worsen outcomes in inflammatory conditions where iron is sequestered 3

4. Do not overlook the mortality risk—low TIBC predicts increased all-cause mortality and requires aggressive investigation of underlying disease 6, 7

5. Do not forget to check hemoglobin/hematocrit—the presence or absence of anemia significantly changes management 2

Bottom Line Algorithm

Step 1: Check CRP, ESR, CBC, serum iron (if not done), albumin, creatinine
Step 2: Calculate transferrin saturation
Step 3: If inflammation present → investigate underlying chronic disease
Step 4: If TSAT <16% and ferritin 30-100 ng/mL → consider trial of IV iron after treating inflammation
Step 5: If no response to iron trial → inflammatory iron block, stop iron
Step 6: Address malnutrition if albumin/protein low
Step 7: Monitor closely given mortality risk associated with low TIBC